Literature DB >> 2696574

Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells?

L Hertz1.   

Abstract

A novel hypothesis is suggested for the pathogenesis of Alzheimer's disease, i.e. that a degeneration of adrenergic neurons in locus coeruleus and/or of serotonergic neurons in the raphe nuclei leads to impairment in metabolic and functional interactions between neurons and astrocytes (in the cerebral cortex and hippocampus as well as in nucleus basalis magnocellularis), and that a resulting deficient supply of substrates and failing energy metabolism in both neurons and astrocytes causes neuronal cell death in these areas and thus interference with additional transmitter systems. The hypothesis is based on (1) the topographical distribution of ascending pathways from locus coeruleus and the raphe nuclei; (2) the peculiar termination of many of these fibres in varicosities, from which released transmitter molecules reach their targets by diffusion, rather than in genuine synapses, suggesting a partly non-neuronal target; (3) the effects of locus coeruleus lesions in experimental animals; (4) the emergence of new knowledge in cellular neurobiology, indicating profound metabolic and functional interactions between neurons and astrocytes; and (5) the effects of adrenergic and serotonergic agonists upon metabolism and function in rodent astrocytes and neurons. These compounds influence energy metabolism, membrane transport of potassium and production of growth factors in astrocytes, and glutamate release from glutamatergic neurons. They thus influence essential metabolic interactions between neurons and astrocytes, as well as neuronal-astrocytic interactions in potassium homeostasis at the cellular level. Obviously, neither the individual findings alone, nor their combination into a conceptual framework, prove the correctness of the hypothesis. However, they do provide a basis for further experimental work, using postmortem brain tissue from Alzheimer's patients and lesion studies in rodents, which can confirm or refute the hypothesis.

Entities:  

Mesh:

Year:  1989        PMID: 2696574     DOI: 10.1016/0165-0173(89)90017-9

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  12 in total

Review 1.  Molecular mechanisms of memory formation.

Authors:  K T Ng; M E Gibbs; S F Crowe; G L Sedman; F Hua; W Zhao; B O'Dowd; N Rickard; C L Gibbs; E Syková
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 2.  Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?

Authors:  Marie Gibbs
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

Review 3.  Astrocytic glycogen metabolism in the healthy and diseased brain.

Authors:  Lasse K Bak; Anne B Walls; Arne Schousboe; Helle S Waagepetersen
Journal:  J Biol Chem       Date:  2018-03-23       Impact factor: 5.157

4.  Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 5.  What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

Authors:  J Vion-Dury; D J Meyerhoff; P J Cozzone; M W Weiner
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

6.  Does Alzheimer's disease begin in the brainstem?

Authors:  G Simic; G Stanic; M Mladinov; N Jovanov-Milosevic; I Kostovic; P R Hof
Journal:  Neuropathol Appl Neurobiol       Date:  2009-08-04       Impact factor: 8.090

Review 7.  Seeding neuritic plaques from the distance: a possible role for brainstem neurons in the development of Alzheimer's disease pathology.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Neurodegener Dis       Date:  2008-03-06       Impact factor: 2.977

8.  Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.

Authors:  David Braun; Jose L M Madrigal; Douglas L Feinstein
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

9.  Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.

Authors:  Christine M Dengler-Crish; Matthew A Smith; Gina N Wilson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Trigeminal, Visceral and Vestibular Inputs May Improve Cognitive Functions by Acting through the Locus Coeruleus and the Ascending Reticular Activating System: A New Hypothesis.

Authors:  Vincenzo De Cicco; Maria P Tramonti Fantozzi; Enrico Cataldo; Massimo Barresi; Luca Bruschini; Ugo Faraguna; Diego Manzoni
Journal:  Front Neuroanat       Date:  2018-01-08       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.